OP-3- induced morphongenesis
AssigneeCreative BioMolecules, Inc.
InventorsHermann Oppermann, Engin Ozkaynak, Thangavel Kuberasampath, David C. Rueger, Roy H. L. Pang, Charles M. Cohen
Life of this patent
Estimating the term…
Abstract
Disclosed are (1) nucleic acid and amino acid sequences for a novel morphogenic protein; (2) methods for producing and expressing the protein in a biologically active form; and (3) methods for utilizing the protein to induce tissue morphogenesis in a mammal, including methods for increasing a progenitor cell population in a mammal, methods for stimulating progenitor cells to differentiate and maintain their differentiated phenotype in vivo or in vitro, methods for inducing tissue-specific growth in vivo and methods for the replacement of diseased or damaged tissue in vivo.
Claims8
An in vitro or ex vivo composition comprising a progenitor cell population isolated from a renewable or conditionally renewable tissue and at least a fragment of OP-3, wherein said fragment induces endochondral bone formation in an in vivo assay.
Dependencies are inferred from the claim text.